In addition, DNMT inhibition was discovered to rejuvenate tumor-infiltrating CD8 T cells and suppress the development of regulatory T cells [45–47], which may partly account for our previous observation that ZVI@CMC improves anti-tumor immunity and modulates an immunostimulatory tumor microenvironment [29]. This evidence concerns the gene CD8A and neoplasm.